课题基金 / 基金详情

项目摘要

项目成果

Melody Y Zeng的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract The gut microbiota has a plethora of important functions that promote human health. The impact of maternal gut microbiota on neonatal health, however, remains largely unknown. Sepsis is an important cause of morbidity and mortality among newborn infants, particularly in preterm infants. Our preliminary studies have unraveled a previously unknown function of the gut microbiota to induce antigen-specific IgG antibodies under homeostatic conditions, which can rapidly mediate clearance of pathogens bearing conserved IgG antigens during systemic infection. Importantly, we found robust levels of commensal-specific IgG antibodies in both mouse and human breast milk. Therefore, our central hypothesis is that 1) maternal commensal IgG confers critical protection to the neonate against infection; 2) maternal immunization with IgG-inducing beneficial gut symbiotic bacteria, or IgG-inducing antigens, may be a novel approach to treat neonatal sepsis, which can be caused by dissemination of gut bacteria. This hypothesis will be tested through three specific aims: 1) determine the role of maternal gut microbiota-induced IgG in neonatal enteric infection, 2) identify and characterize gut symbiotic bacteria that induce homeostatic antigen-specific IgG antibodies, and 3) determine whether maternal immunization with IgG-inducing bacteria or antigens confers protection in the neonate. The objective of the current application is to harness gut microbiota-induced IgG to develop therapeutics for neonatal sepsis, and for the PI to learn new skills such as developing neonatal infection models and vaccine nanoparticles, which are important for her to develop an independent research program with a focus on the gut microbiota and neonatal health. The research is significant because these studies will unravel potentially novel and effective approaches to treat neonatal sepsis. The distinguished mentoring team will allow the PI to complete the proposed studies with new skills and transition to independence in a new field of study. In addition, the excellent research environment of the University of Michigan will provide exceptional support for the proposed studies and the PI's career development.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
LOS in The Dysbiotic Gut.
肠道菌群失调中的 LOS。
DOI: 10.1016/j.chom.2019.12.009
发表时间: 2020
期刊: Cell host & microbe
影响因子: 30.3
作者: [Sanidad,KatherineZ, Zeng,MelodyY]
通讯作者: Zeng,MelodyY
DOI: 10.1126/science.abl3631
发表时间: 2021-08-27
期刊: Science (New York, N.Y.)
影响因子: --
作者: [Amir M, Zeng MY]
通讯作者: Zeng MY
Sex-biased gut dopamine signaling in multiple sclerosis.
多发性硬化症中性别偏见的肠道多巴胺信号传导。
DOI: 10.1016/j.immuni.2023.11.016
发表时间: 2023
期刊: Immunity
影响因子: 32.4
作者: [Yu,Shui, Zeng,MelodyY]
通讯作者: Zeng,MelodyY
The Gut-Liver Axis in Pediatric Liver Health and Disease.
小儿肝脏健康和疾病中的肠道轴。
DOI: 10.3390/microorganisms11030597
发表时间: 2023-02-27
期刊: Microorganisms
影响因子: 4.5
作者: [Rager SL, Zeng MY]
通讯作者: Zeng MY
7
    Megakaryocyte regulation by the gut microbiome
    Immune regulation by the gut microbiome at the maternal-fetal interface
    Immune regulation by the gut microbiome at the maternal-fetal interface
    Role of gut microbiota-induced IgG in enteric host defense
    国内基金
    海外基金
    Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
    • 批准号:
      2022J011295
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2022
    • 负责人:
      王亚伟
    • 依托单位:
    结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究